| ZBTB16 |
ZBTB16, PLZF, ZNF145: Zinc finger and BTB domain-containing protein 16 |
NR5A1 |
NR5A1, AD4BP, FTZF1, SF1: Steroidogenic factor 1 |
4.502 |
Evidence |
|
| PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
MPP6 |
MPP6, VAM1: MAGUK p55 subfamily member 6 |
4.502 |
Evidence |
|
| RRAD |
RRAD, RAD: GTP-binding protein RAD |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
4.502 |
Evidence |
|
| FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
CTTN |
CTTN, EMS1: Src substrate cortactin |
4.502 |
Evidence |
|
| IRS1 |
IRS1: Insulin receptor substrate 1 |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
4.502 |
Evidence |
|
| HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
HSPB8 |
HSPB8, CRYAC, PP1629, E2IG1, HSP22: Heat shock protein beta-8 |
4.502 |
Evidence |
|
| F5 |
F5: Coagulation factor V precursor |
GAD2 |
GAD2, GAD65: Glutamate decarboxylase 2 |
4.502 |
Evidence |
|
| IGF1R |
IGF1R: Insulin-like growth factor 1 receptor precursor |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
4.502 |
Evidence |
|
| CLEC3B |
CLEC3B, TNA: Tetranectin precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
4.502 |
Evidence |
|
| S100B |
S100B: Protein S100-B |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
4.502 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
4.502 |
Evidence |
O
|
| HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
VDP |
DKFZp451D234: Putative uncharacterized protein DKFZp451D234 |
4.502 |
Evidence |
|
| HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
SF3A1 |
SF3A1, SAP114: Splicing factor 3 subunit 1 |
4.502 |
Evidence |
|
| SLC37A4 |
G6PC, G6PT: Glucose-6-phosphatase |
C6 |
C6: Complement component C6 precursor |
4.502 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
SLC37A4 |
G6PC, G6PT: Glucose-6-phosphatase |
4.502 |
Evidence |
|
| CPSF5 |
NUDT21, CFIM25, CPSF25, CPSF5: Cleavage and polyadenylation specificity factor s |
CSNK2A1 |
CSNK2A1: CSNK2A1 protein |
4.502 |
Evidence |
|
| EEF2 |
EEF2, EF2: Elongation factor 2 |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
4.497 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SYN1 |
SYN1: Synapsin-1 |
4.497 |
Evidence |
|
| PRMT5 |
PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
4.497 |
Evidence |
|
| PRMT5 |
PRMT5, HRMT1L5, IBP72, JBP1, SKB1: Protein arginine N-methyltransferase 5 |
FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
4.497 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
4.49 |
Evidence |
|
| ACE |
ACE, DCP, DCP1: Angiotensin-converting enzyme, testis-specific isoform precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
4.487 |
Evidence |
|
| MS4A1 |
MS4A1, CD20: B-lymphocyte antigen CD20 |
PRKCE |
PRKCE, PKCE: Protein kinase C epsilon type |
4.487 |
Evidence |
|
| GHR |
GHR: Growth hormone receptor precursor |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
4.487 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
4.487 |
Evidence |
|
-